Drugs / 99mTc-MSA-ICG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05039905 | Feb → Dec 2021 | lung cancer | Korea University Guro Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-MSA-ICG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05039905 ↗ |
| Modality | Diagnostic / imaging agent | “radioactive fluorescent dual contrast agent” NCT05039905 ↗ |
| Route | Other | “Intratumoral injection” NCT05039905 ↗ |